BMD alone and in combination with the Gail score helps to quantify the risk for breast cancer in postmenopausal women.
Bone mineral density (BMD) alone and in combination with the Gail score helps to quantify the risk for breast cancer in postmenopausal women, according to the findings of a prospective study involving almost 10,000 participants of the Women's Health Initiative.
After an average of 8.5 years of follow-up, researchers calculated hazard ratios for incident breast cancer of 1.35 (95% confidence interval [CI], 1.05–1.73) for high Gail score and 1.25 (95% CI, 1.11–1.40) for each unit of increase in total hip BMD T-score. Women with both BMD and Gail score above the median had a sharp increase in risk for breast cancer, suggesting an interaction between the two factors.
The findings seemed uninfluenced by body mass index, race/ethnicity, baseline hormone use, or physical activity. The researchers concluded that further investigation is needed to determine whether incorporating BMD and the Gail score with other risk factors, such as breast density, could further identify women at greatest risk for the disease.
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More